oral glp-1 drugs in development Timeline of discovery and clinical development. (a) Key events Peptidyl and Non-Peptidyl Oral Glucagon-Like
Description
A 2025 survey by KFF reported that 27 percent of people taking GLP-1 medications who had health insurance said that they still had to pay the full cost of the drugs out of pocket, however
10.1186/s12933-018-0689-9 89 YangC.-T.YaoW.-Y.YangC.-Y.PengZ.-Y.OuH.-T.KuoS
The first few weeks of using these drugs may cause stomach discomfort and diarrhea but this usually improves with time
This process was repeated 10,000 times to estimate the median and 95 % confidence interval (CIs) of the drug effects at each time point for each subgroup
10.1152/ajpendo.1996.271.3.E458
doi: 10.1038/nm.3009
